KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 141 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $591,000 | -21.6% | 59,200 | 0.0% | 0.06% | -21.3% |
| Q1 2015 | $754,000 | -10.0% | 59,200 | 0.0% | 0.08% | -16.7% |
| Q4 2014 | $838,000 | +2.9% | 59,200 | 0.0% | 0.09% | -6.2% |
| Q3 2014 | $814,000 | -97.6% | 59,200 | -98.3% | 0.10% | -97.3% |
| Q3 2013 | $34,218,000 | -31.2% | 3,391,261 | -49.1% | 3.57% | -45.9% |
| Q2 2013 | $49,745,000 | – | 6,659,285 | – | 6.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |